Skip to main content

Melatonin (N-acetyl-5-Methoxytryptamine)

  • Chapter
Dietary Supplements

Part of the book series: Forensic Science and Medicine ((FSM))

Abstract

Melatonin was isolated in the late 1950s and had been administered intravenously by 1960. Studies of its sedative/hypnotic effects soon followed (Dawson and Encel, 1993). Melatonin promotion to the public began in the mid-1990s.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anonymous. Melatonin. Briggs Update-Drugs in Pregnancy and lactation. 2002; 14: 28–9.

    Google Scholar 

  • Anonymous. Melatonin. Med Lett Drugs Ther 1995; 37: 111–2.

    Google Scholar 

  • Arendt J. In what circumstances is melatonin a useful sleep therapy? Consensus statement

    Google Scholar 

  • WFSRS Focus Group, Dresden, November 1999. J Sleep Res 2000; 9: 397–8.

    Google Scholar 

  • Bardazzi F, Placucci F, Neri I, et al. Fixed drug eruption due to melatonin. Acta Derm-Venereol 1998; 78: 69–70.

    Article  PubMed  CAS  Google Scholar 

  • Bursztajn HJ. Melatonin therapy: from benzodiazepine-dependent insomnia to authenticity and autonomy [editorial]. Arch Intern Med 1999; 159: 2393–4.

    Article  PubMed  CAS  Google Scholar 

  • Carman JS, Post RM, Buswell R, Goodwin FK. Negative effects of melatonin on depression. Am J Psychiatry 1976; 133: 1181–6.

    PubMed  CAS  Google Scholar 

  • Citera G, Arias MA, Maldonado-Cocco JA, et al., The effect of melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol 2000; 19: 9–13.

    Article  PubMed  CAS  Google Scholar 

  • Dagan Y, Zisapel N, Nof D, et al. Rapid reversal of tolerance to benzodiazepine hypnotics by treatment with oral melatonin: a case report. Eur Neuropsychopharmacol 1997; 7: 157–69.

    Article  PubMed  CAS  Google Scholar 

  • Dalton EJ, Rotondi D, Levitan RD, et al. Use of slow-release melatonin in treatment-resistant depression. J Psychiatry Neurosci 2000; 25: 48–52.

    PubMed  CAS  PubMed Central  Google Scholar 

  • Dawson D, Encel N. Melatonin and sleep in humans. J Pineal Res 1993; 15: 1–12.

    Article  PubMed  CAS  Google Scholar 

  • DeMuro RL, Nafziger AN, Blask DE, et al. The absolute bioavailability of oral melatonin. J Clin Pharmacol 2000; 40: 781–4.

    Article  PubMed  CAS  Google Scholar 

  • Ellis CM, Lemmens G, Parkes JD. Melatonin and insomnia. J Sleep Res 1996;5:61#-35.

    Google Scholar 

  • Force RW, Hansen L, Bedell M. Psychotic episode after melatonin [letter]. Ann Pharmacother 1997; 31: 1408.

    PubMed  CAS  Google Scholar 

  • Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995; 346: 541–4.

    Article  PubMed  CAS  Google Scholar 

  • Garfinkel D, Zisapel N, Wainstein J, Laudon M. Facilitation of benzodiazepine disontinuation by melatonin. Arch Intern Med 1999; 159: 2456–60.

    Article  PubMed  CAS  Google Scholar 

  • Ghielmini M, Pagani O, de Jong J, et al. Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer. Br J Cancer 1999; 80: 1058–61.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Gordon N. The therapeutics of melatonin: a paediatric perspective. Brain Dev 2000; 22: 213–7.

    Article  PubMed  CAS  Google Scholar 

  • Hahm H, Kujawa J, Augsburger L. Comparison of melatonin products against USP nutritional supplements standards and other criteria. J Am Pharm Assoc 1999; 39: 27–31.

    CAS  Google Scholar 

  • Haimov I, Lavie P, Laudon M, et al. Melatonin replacement therapy of elderly insomniacs. Sleep 1995; 18: 598–603.

    PubMed  CAS  Google Scholar 

  • Hao H. Melatonin does not shift circadian phase in baboons. J Clin Endocrinol Metab 2000; 85: 3618–22.

    PubMed  CAS  Google Scholar 

  • Hartter S, Grozinger M, Weigmann H, et al. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther 2000; 67: 1–6.

    Article  PubMed  CAS  Google Scholar 

  • Harumi T, Matsushima S. Separation and assay methods for melatonin and its precursors. J Chromatogr B Biomed Sci App12000; 747: 95–110.

    Google Scholar 

  • Herxheimer A, Petrie KJ. Melatonin for preventing and treating jet lag (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford: Update Software, 2001.

    Google Scholar 

  • Holliman BJ, Chyka PA. Problems in assessment of acute melatonin overdose. South Med J 1997; 90: 451–3.

    Article  PubMed  CAS  Google Scholar 

  • Iinuma F, Hamase K, Matsubayashi S, et al. Sensitive determination of melatonin by precolumn derivatization and reversed-phase high-performance liquid chromatography. J Chromatogr A 1999; 835: 67–72.

    Article  PubMed  CAS  Google Scholar 

  • James M, Trema MO, Jones JS, Krohmer JR. Can melatonin improve adaptation to night shift? Am J Emerg Med 1998; 16: 367–70.

    Article  PubMed  CAS  Google Scholar 

  • Lewy AJ, Bauer VK, Cutler NL, Sack RL. Melatonin treatment of winter depression: a pilot study. Psychiatry Res 1998; 77: 57–61.

    Article  PubMed  CAS  Google Scholar 

  • Lissoni P, Barni S, Mandala M, et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumor patients with poor clinical status. Eur J Cancer 1999; 35: 1688–92.

    Article  PubMed  CAS  Google Scholar 

  • Lissoni P, Barni S, Meregalli S, et al. Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. BJM 1995; 71: 854–6.

    CAS  Google Scholar 

  • Lissoni P, Barni S, Tancini G, et al., A randomized study with subcutaneous low-dose interleukin 2 alone v interleukin 2 plus the pineal hormone melatonin in advanced solid neoplasms other than renal cancer and melanoma. Br J Cancer 1994; 69: 196–9.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Lockley SW, Skeene DJ, James K, et al. Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol 2000; 164: R1–6.

    Article  PubMed  CAS  Google Scholar 

  • Lusardi P, Piazza E, Fogari R. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study. Br J Clin Pharmacol 2000; 49: 423–7.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Monti JM, Cardinali DP. A critical assessment of the melatonin effect on sleep in humans. Biol Signals Recept 2000; 9: 328–39.

    Article  PubMed  CAS  Google Scholar 

  • Naguib M, Samarkandi AH. The comparative dose-response effects of melatonin and midazolam for premedication of adult patients: a double-blinded, placebo-controlled study. Anesth Analg 2000; 91: 473–9.

    PubMed  CAS  Google Scholar 

  • Ohta Y, Kongo M, Sasaki E, et al. Preventive effect of melatonin on the progression of carbon tetrachloride-induced acute liver injury in rats. Adv Exp Med Biol 1999; 467: 327–32.

    Article  PubMed  CAS  Google Scholar 

  • Pierce A. The American Pharmaceutical Association practical guide to natural medicines. New York: The Stonesong Press; 1999. p. 19.

    Google Scholar 

  • Papavasiliou PS, Cotzias GC, Duby SE, et al. Melatonin and parkinsonism [letter]. JAMA 1972; 221: 88–9.

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez MA, Cabanillas F, Dang NH, et al. Lymphocyte changes in lymphoma patients receiving melatonin plus CHOP chemotherapy. Proc Ann Meet Am Soc Clin Oncol 2000;19:Abstract 72.

    Google Scholar 

  • Rosenberg SI, Silverstein H, Rowan PT, Olds MJ. Effect of melatonin on tinnitus. Laryngoscope 1998; 108: 305–10.

    Article  PubMed  CAS  Google Scholar 

  • Sack RL, Brandes RW, Kendall AR, Lewy AJ. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 2000; 343: 1070–7.

    Article  PubMed  CAS  Google Scholar 

  • Sanders DC, Chaturvedi AK, Hordinsky JR. Melatonin: aeromedical, toxicopharmacologial, and analytic aspects. J Anal Toxicol 1999; 23: 159–67.

    Article  PubMed  CAS  Google Scholar 

  • Shamir E, Laudon M, Barak Y, et al. Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin Psychiatry 2000; 61: 373–7.

    Article  PubMed  CAS  Google Scholar 

  • Shaughnessy AF. Melatonin: miracle or not? Fam Pract Recert 1996; 18: 46–8.

    Google Scholar 

  • Sheldon SH. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 1998; 351: 1254.

    Article  PubMed  CAS  Google Scholar 

  • von Bahr C, Ursing C, Yasui N, et al. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects—an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. Eur J Clin Pharmacol 2000; 56: 123–7.

    Article  Google Scholar 

  • Waldhauser F, Dietzel M. Daily and annual rhythms in human melatonin secretion: role in puberty control. Ann NY Acad Sci 1985; 453: 205–14.

    Article  PubMed  CAS  Google Scholar 

  • Williamson BL, Tomlinson AJ, Mishra PK, et al. Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from 1-tryptophan associated with eosinophilia-myalgia syndrome. Chem Res Toxicol 1998; 11: 234–40.

    Article  PubMed  CAS  Google Scholar 

  • Wright SW, Lawrence LM, Wrenn KD, et al. Randomized clinical trial of melatonin after nightshift work: efficacy and neuropsychologic effects. Ann Emerg Med 1998; 32: 334–40.

    Article  PubMed  CAS  Google Scholar 

  • Wurzburger RJ, Kawashima K, Miller RL, Spector S. Determination of rat pineal gland melatonin content by a radioimmunoassay. Life Sci 1976; 18: 867–77.

    Article  PubMed  CAS  Google Scholar 

  • Yie SM, Johansson E, Brown GM. Competitive solid-phase enzyme immunoassay for melatonin in human and rat serum and rat pineal gland. Clin Chem 1993; 39: 2322–5.

    PubMed  CAS  Google Scholar 

  • Zisapel N. The use of melatonin for the treatment of insomnia. Biol Signals Recept 1999; 8: 84–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sullivan, A., Cupp, M.J., Tracy, T.S. (2003). Melatonin (N-acetyl-5-Methoxytryptamine). In: Cupp, M.J., Tracy, T.S. (eds) Dietary Supplements. Forensic Science and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-303-3_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-303-3_17

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9726-7

  • Online ISBN: 978-1-59259-303-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics